Abstract
Presently, facilitated percutaneous coronary intervention (PCI) in patients remains controversial. We evaluated the efficacy and safety of facilitated PCI, intravenous low-dose rt-PA administration prior to urgent PCI, in Chinese patients < 70 years of age with ST-segment elevation myocardial infarction. Our results suggest that the age and dosage of thrombolytics should be noticed seriously when considering facilitated PCI.
Publication types
-
Comparative Study
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aged
-
Angioplasty, Balloon, Coronary*
-
China
-
Coronary Angiography
-
Coronary Circulation
-
Fibrinolytic Agents / therapeutic use*
-
Humans
-
Myocardial Infarction / therapy*
-
Retrospective Studies
-
Stents
-
Thrombolytic Therapy
-
Tissue Plasminogen Activator / therapeutic use*
-
Vascular Patency
Substances
-
Fibrinolytic Agents
-
Tissue Plasminogen Activator